Ident. | Authors (with country if any) | Title |
---|
000652 |
E. Lohmann [France] ; S. Thobois [France] ; S. Lesage [France] ; E. Broussolle [France] ; S. Tezenas Du Montcel [France] ; M.-J. Ribeiro [France] ; P. Remy [France] ; A. Pelissolo [France] ; B. Dubois [France] ; L. Mallet [France] ; P. Pollak [France] ; Yves Agid [France] ; A. Brice [France] | A multidisciplinary study of patients with early-onset PD with and without parkin mutations |
000771 |
Werner Poewe [Autriche] ; S. Gauthier [Canada] ; D. Aarsland [Norvège] ; J. B. Leverenz [États-Unis] ; P. Barone [Italie] ; D. Weintraub [États-Unis] ; E. Tolosa [Espagne] ; B. Dubois [France] | Diagnosis and management of Parkinson's disease dementia |
000903 |
C. F. Lippa [États-Unis] ; J. E. Duda [États-Unis] ; M. Grossman [États-Unis] ; H. I. Hurtig [États-Unis] ; D. Aarsland [Norvège] ; B. F. Boeve [États-Unis] ; D. J. Brooks [Royaume-Uni] ; D. W. Dickson [États-Unis] ; B. Dubois [France] ; M. Emre [Turquie] ; S. Fahn [États-Unis] ; J. M. Farmer [États-Unis] ; D. Galasko [États-Unis] ; J. E. Galvin [États-Unis] ; C. G. Goetz [États-Unis] ; J. H. Growdon [États-Unis] ; K. A. Gwinn-Hardy [États-Unis] ; J. Hardy [États-Unis] ; P. Heutink [Pays-Bas] ; T. Iwatsubo [Japon] ; K. Kosaka [Japon] ; V. M.-Y. Lee [États-Unis] ; J. B. Leverenz ; E. Masliah [États-Unis] ; I. G. Mckeith [Royaume-Uni] ; R. L. Nussbaum ; C. W. Olanow ; B. M. Ravina ; A. B. Singleton ; C. M. Tanner ; J. Q. Trojanowski ; Z. K. Wszolek [États-Unis] | DLB and PDD boundary issues : Diagnosis, treatment, molecular pathology, and biomarkers |
000914 |
Annie Lannuzel [France] ; G. U. Höglinger [Allemagne] ; S. Verhaeghe [France] ; L. Gire [France] ; S. Belson [France] ; M. Escobar-Khondiker [France] ; P. Poullain [France] ; W. H. Oertel [Allemagne] ; E. C. Hirsch [France] ; B. Dubois [France] ; M. Ruberg [France] | Atypical parkinsonism in Guadeloupe : a common risk factor for two closely related phenotypes? |
000B35 |
M. Samuel [Royaume-Uni] ; V. Voon [États-Unis] ; V. Czernecki [France] ; B. Pillon [France] ; J. L. Houeto [France] ; M. L. Welter [France] ; V. Mesnage [France] ; Yves Agid [France] ; B. Dubois [France] | Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?. Commentary |
000B61 |
B. Dubois [France] ; A. Slachevsky [France, Chili] ; B. Pillon [France] ; R. Beato [France] ; J. M. Villalponda [France] ; I. Litvan [États-Unis] | "Applause sign" helps to discriminate PSP from FTD and PD |
000C27 |
N. Scarmeas [États-Unis, Grèce] ; G. M. Hadjigeorgiou [Grèce] ; A. Papadimitriou [Grèce] ; B. Dubois [France] ; M. Sarazin [France] ; J. Brandt [États-Unis] ; M. Albert [États-Unis] ; K. Marder [États-Unis] ; K. Bell [États-Unis] ; L. S. Honig [États-Unis] ; D. Wegesin [États-Unis] ; Y. Stern [États-Unis] | Motor signs during the course of Alzheimer disease |
000D09 |
B. Dubois [France] ; R. Beato [France] ; J.-M. Villalpando [France] | L'évaluation neuropsychologique peut contribuer au diagnostic des maladies du mouvement |
000D53 |
Yves Agid [France] ; I. Arnulf [France] ; P. Bejjani [États-Unis] ; F. Bloch [France] ; A. M. Bonnet [France] ; P. Damier [France] ; B. Dubois [France] ; C. Francois [France] ; J. L. Houeto [France] ; D. Iacono [France] ; C. Karachi [France] ; V. Mesnage [France] ; O. Messouak [France] ; M. Vidailhet [France] ; M. L. Welter [France] ; J. Yelnik [France] | Parkinson's disease is a neuropsychiatric disorder |
000E21 |
P. Auquier [France] ; C. Sapin [France] ; M. Ziegler [France] ; F. Tison [France] ; A. Destee [France] ; B. Dubois [France] ; M. P. Allicar [France] ; J.-L. Thibault [France] ; C. Jenkinson [Royaume-Uni] ; V. Peto [Royaume-Uni] | Validation en langue française d'un questionnaire de qualité de vie dans la maladie de Parkinson : le Parkinson's disease questionnaire - PDQ-39 |
000F16 |
V. Czernecki [France] ; B. Pillon [France] ; J. L. Houeto [France] ; J. B. Pochon [France] ; R. Levy [France] ; B. Dubois [France] | Motivation, reward, and Parkinson's disease: influence of dopatherapy |
001022 |
M. Sarazin [France] ; B. Deweer [France] ; B. Pillon [France] ; A. Merkl [France] ; B. Dubois [France] | Apprentissage procédural et maladie de Parkinson: implication des boucles striato-frontales |
001361 |
C. Le Bras [France] ; B. Pillon [France] ; P. Damier [France] ; B. Dubois [France] | At which steps of spatial working memory processing do striatofrontal circuits intervene in humans? |
001365 |
M. A. Bedard [Canada] ; B. Pillon [France] ; B. Dubois [France] ; N. Duchesne [Canada] ; H. Masson [Canada] ; Yves Agid [France] | Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome |
001440 |
B. Pillon [France] ; B. Deweer [France] ; M. Vidailhet [France] ; A.-M. Bonnet [France] ; V. Hahn-Barma [France] ; B. Dubois [France] | Is impaired memory for spatial location in Parkinson's disease domain specific or dependent on 'strategic' processes? |
001466 |
M.-A. Bedard [Canada] ; F. El Massioui [France] ; C. Malapani [France] ; B. Dubois [France] ; B. Pillon [France] ; B. Renault [France] ; Yves Agid [France] | Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist |
001484 |
B. Dubois [France] | Troubles cognitifs de la maladie de Parkinson : Maladie de Parkinson - 2e partie |
001564 |
B. Pillon [France] ; S. Ertle [France] ; B. Deweer [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; B. Dubois [France] | Memory for spatial location in 'de novo' parkinsonian patients |
001586 |
B. Dubois [France] ; B. Pillon [France] | Cognitive deficits in Parkinson's disease |
001716 |
B. Pillon [France] ; N. Gouider-Khouja ; B. Deweer ; M. Vidailhet ; C. Malapani ; B. Dubois ; Yves Agid [France] | Neuropsychological pattern of striatonigral degeneration : comparison with Parkinson's disease and progressive supranuclear palsy |
001745 |
A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine |
001769 |
B. Dubois [France] ; C. Malapani ; M. Verin ; P. Rogelet ; B. Deweer ; B. Pillon | Fonctions cognitives et noyaux gris centraux : le modèle de la maladie de Parkinson |
001797 |
R. Marconi [France] ; D. Lefebvre-Caparros ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; B. Dubois [France] ; Yves Agid [France] | Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology |
001799 |
C. Malapani [France] ; B. Pillon ; B. Dubois ; Yves Agid [France] | Impaired simultaneous cognitive task performance in Parkinson's disease : a dopamine-related dysfunction |
001813 |
B. Pillon [France] ; B. Deweer ; A. Michon ; C. Malapani ; Yves Agid [France] ; B. Dubois | Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits ? : Comparison with Alzheimer's, Parkinson's, and Huntington's diseases |
001824 |
B. Dubois [France] | Syndromes parkinsoniens : étiologie, diagnostic, traitement |
001880 |
B. Pillon [France] ; B. Deweer ; Yves Agid [France] ; B. Dubois | Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseasees |
001978 |
A. Guillard [France] ; B. Dubois ; A. Rascol ; H. Allain | Passé, présent et futur du Parkinsonien |
001A01 |
B. Pillon ; B. Dubois ; A. Ploska ; Yves Agid [France] | Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy |
001A13 |
J. Blin [France] ; B. Dubois ; A. M. Bonnet ; M. Vidailhet ; M. Brandabur ; Yves Agid [France] | Does ageing aggravate Parkinsonian disability ? |
001A63 |
B. Dubois ; B. Pillon ; N. Sternic ; F. Lhermitte ; Yves Agid [France] | Age-induced cognitive disturbances in Parkinson's disease |
001A98 |
E. Pourcher ; A.-M. Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France] | Effects of etybenzatropine and diazepam on Levodopa-induced diphasic dyskinesias in Parkinson's disease |
001A99 |
B. Pillon ; B. Dubois ; G. Cusimano ; A.-M. Bonnet ; F. Lhermitte ; Yves Agid [France] | Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? |
001B00 |
B. Pillon ; B. Dubois ; A.-M. Bonnet ; M. Esteguy ; J. Guimaraes ; J.-M. Vigouret ; F. Lhermitte ; Yves Agid [France] | Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test |
001B23 |
B. Dubois ; B. Pillon ; F. Legault ; Yves Agid [France] ; F. Lhermitte | Slowing of cognitive processing in progressive supranuclear palsy: a comparison with Parkinson's disease |
001B65 |
B. Dubois ; F. Danze ; B. Pillon ; G. Cusimano ; F. Lhermitte ; Yves Agid [France] | Cholinergic-dependent cognitive deficits in Parkinson's disease |
001B73 |
B. Dubois ; Yves Agid [France] | Les agonistes dopaminergiques dans la maladie de Parkinson |
001B79 |
B. Pillon ; B. Dubois ; F. Lhermitte ; Yves Agid [France] | Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease |
001B81 |
B. Dubois ; B. Pillon ; H. De Saxce ; F. Lhermitte ; Yves Agid [France] | Disappearance of Parkinsonian signs after spontaneous vascular ``thalamotomy'' |
001B96 |
J. C. Monfort ; F. Javoy-Agid ; J. J. Hauw ; B. Dubois ; Yves Agid [France] | Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index |